3rd Quarter - Report — PARRY, ROMANI, DECONCINI & SYMMS for PLEXUS WORLDWIDE (2020)

Firm

PARRY, ROMANI, DECONCINI & SYMMS

Client

PLEXUS WORLDWIDE

Income

—

Expenses

—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

U.S. Food, Drug and Cosmetic Act (FDCA), to add language regarding CBD

Lobbyist	Covered position, as disclosed
ROMANO ROMANI	—
STEVE SYMMS	—

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Food & Drug Administration (FDA)

Chemicals/Chemical Industry CHM

HR 5587, To amend the FDA and Cosmetic Act with respect to the regulation of hemp derived cannabidiol contained substances.

Lobbyist	Covered position, as disclosed
ROMANO ROMANI	—
STEVE SYMMS	—

Contacted: Office of Management & Budget (OMB); Food & Drug Administration (FDA); SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5587 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.